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/13. Kinetics of Coagulation and Immunological Processes
H. C. Hsurnn
Inhibition is one of the most important phenomena observed when the presence
of antibodies complicates the coagulation process. Since study of the inhibition of
an enzymatic pfocess requires the use of enzyme kinetics, a discussion of the kine-
tics of coagulation and immunological pfocesses would be appropriate for this
conference, if it did not involve a .very difficult problem. It would be relatively
easy to give a detailed treatment of the specific kinetic problems encountered in
coagulation and immunology, but not without touching on certain mathematical
problems, that do not lend themselves to a brief oral presentation. I therefore
thought it might be more useful to discuss the kinetic approach in general and
to try to reach some conclusions as to how kinetics can best be applied in the field
'we are interested in.
The study of coagulation, like any othef kind of biochemical reseafch, can be
done via two different pathways: one tfies to sepafate the enzymes involved and
studies the separate steps 
.of the reaction ) 0r one studies the kinetics of alatgepart
of the reaction process. This means: one extracts information from the functional
reaction of the system to independently variable expedmental citcumstances.
These two appfoaches are complementary.They are used in combination in any
kind of enzymological research. Yet they are of unequal status. Separation is
looked upon much more favorably than kinetics, no doubt because the final stabi-
ltzation of our insights is most often determined by the level achieved in the puri-
fication of the rcactants involved. But it is usually kinetics which leads us when we
are exploring a nev/ field and tells us whete to look for the next pure e{rzyme, and
it is kinetics as well thatfinally characterizes the functions of the isolated entities.
This is illustrated fot instance by recent developments in the field of allosteric
interactions (6).
A kinetic analysis involves a numbef of separate steps. plrtr, a reacti.on mecha-
nism is postulated in terms of a set of chemical rcaction equations. Second,two sets
of mathematical fotmulas are derived from these reaction equations, namely the
uelocitjt eqwations that date the rate of change of the concentration of each of the
re^ctants to the reaction constants and the concentrations present at a given mo-
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ment, and the conseruatiofl equatiLns that date the quantity of reactants present at
zero time to the concentrations pfesent at a giYerr moment.
The simplest model of enzymatic action can serve as an illustration. The chemi-
cal formulas are:
1.^+1
u t v
1.a_1
E+P
The velocity equations are:
d S / d t : - k * r . E . S  + k - r . C
dC/dt(: -dE/do : k+r E. S - (k-r + k+r)C
dP/dt :  k*r 'C
The conservation equations are:
E:E+c
S" :S+C+P
After these sets of equations have been set up, the third step is to solve them. It
is here that the mathematician entefs the scene. Even in the simple case given as
an illustration he 'tuill not be able to solve the equations without introducing
simplifying assumptions. When ril/e accept the simplifications S">E and SIP
for instance, the well known >Michaelis-Meritefl ( fotmula will result as a solution
of the above equations; i.e.
dP/dt : *= (where t<- : 
k-''lk*'; 
.
I \m+ )  K+1
The fowrtb step is to check the theoretical predictions against the experimental
observations.
When the fit between these two is close enough, the only conclusion that is
allowed, is that both the proposed reaction mechanism and the assumptions used
to solve the equations are rrot contradicted by the expetimental results. It is in-
herent to the method that it can never prove a hypothetical reactior. mechanism
to be valid. The most tLtat can be achieved is to disprove alternative mechanisms
and to find the simplest reaction scheme that will account for the experimental
observations. Sometimes alternative schemes are possible, and a good kinetic
analysis should indicate such alternatives and thereby lead to furthet experiments.
Now, these considerations are so basic that it hardly seems justified to mention
them at this conference. Everybody knows that in the handbooks on enzymology
l -
c --:
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solutions are presented pertinent to a series of teaction schemes for example in
the cases of competitive and non-competitive inhibition fcomp. ref . Q)]. By using
these solutions, one can bypass steps 1, 2, and 3 and start directly with checking
the results of experiments against standard formulas.
The use of ready-made solutions, however, not only makes it possible to bypass
a lot of work, but also avoids many considerations as to what one is really doing.
The simplifications that the mathematician must introduce to solve the equations
require close supervision by the biochemist, especially when we are working with
non-standard systems as they occur in coagulation and immunology.
The main conclusion that presents itself is therefore, that every attempt at kine-
tics should go through all the steps mentioned. I will attempt to illustrate this on
the basis of a few specific examples.
My first example (4) is the old question of whether a given coagulation factor
acts as a substrate or as an enzyme \)7hen one applies the Michaelis-Menten formu-
la directly one expects that the.reaction velocity will vary hyperbolically with the
concentration of a substrate. This kind of behaviour is entirely dependent upon
the assumed condition of a relative excess of substrate. It is easy to calculate that
with reversal of this assumption (that is E") So instead of S.) E ) the ki-
netic roles of enzyme and substrate are reversed. The role that we assign almost
automatically to the substrate is in reality the role ofthat reactaflt present in excess.
Because nothing can be said a priod about the relative concentrations of reactants
in coagulation processes, any distinction between erizyme and substrate made on
a traditional kinetic basis therefore seems unjustified.
A second example (3) can be taken from the kinetics of prothrombinase forma-
tion. Prothrombinase activity is hyperbolically rclated to phospholipid concen-
tration over a Iarge range of concentrations. In terms of traditional kinetics this
puts the phospholipid in the role of a substrate. As I have aheady mentioned, a
catalytic role is equally feasible. The situation becomes still more complicated when
one tries to account for the fact that high concentrations of phospholipid have an
inhibitory effect. The observed relations between phospholipid concentration and
prothrombinase activity follow directly, however, when one starts from the reac-
tion equations:
X"+Ph. l ip  = X"-Ph. l ip
V"+Ph. l ip  *  V, -Ph" l ip
l"nn' 
liP + V" a Prothrombinase
f"-Ph.lipf X" = prothrombinase
The hyperbolic relationship is a consequence of the reversibility of the adsorp-
tion of the proteins onto the phospholipid and the inhibitory effect is due to the
factthatfactors V" and X" have less chance to meet when a large adsorbing surface
121
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is offered. Here again, direct application of existing formulas would have been rnis-
leading rathet than helpful.
'When 
the inhibitory effect of an antibody is to be evaluated there is agarn no
other way available except to start with a circumscript postulate on the molecular
interactions and work out the kinetics from there on. Therefore, in a kinetic ana-
lysis the most important considetations are those on molecular interactions rather
than those on concentration-velocity relationships and the like.
At first glance, the differences between coagulation processes and immunolo-
gical reactions seem to be quite large. Coagulation is essentially a process of enzy-
matic zymosen activation, whereas antigen-antibody interaction is the formation
of a complex between two or more large molecules. On further consideration, how-
ever, one rcalizes that the first reaction in an enzymatic interaction is the formation
of a complex between substrate and enzyma SThen the substrate is a protein, as
is the case in blood coagulation reactions, there is no essential difference between
the first stage of afl enzym tic reaction and the formation of an antigen-antibody
complex. The chemical forces involved must be of the same type: Coulomb forces,
v. d. Waals forces, hydrogen bonding and hydrophobic interaction. The specificity
of the reaction is equally impressive in both systems and must be explained in
both systems by the complementary pattern of interacting gfoups fathef than
by the specificity of the type of physico-chemical bonding.
The difference between immunological reactions and enzymatic rcactions thus
resides in the second step. After formation of an enzyme-substrate complex,
profound changes occur in the chemical binding pattein within the complex.
These changes involve shifts in covalent bonds within the product. The enzyme
remains essentially unmodified. No covalent alterations occur in antigen-antibody
complexes, but secondary reactions do occur and so may bring about pfecipitation,
inactivation of the antigen and so forth, or they may initiate a further set of reac-
tions such as complement fixation, cell lysis and so on. The fact that covalent changes
do occur in enzym ticreactions but not in immunological ones does not necessarily
serve to distinguish the tvio reactions on kinetic grounds. It results in differences
in changes in free energy, enthalpy and entropy; but due to the complexity of the
molecules there ate a multitude of changes in the so-called weak forces which
can easily mask the thermodynamic effect of the breaking of covalent bonds.
In any case these are thermodynamic values that are not fecognized when
kinetic measurements are catied out at one temperature only'
The other way of distinguishing between these two types of reactions is from the
fact that unmodified enzyme is recovered after a catalytic cycle in an enzymatic
reaction. This is an essential difference, yet it is not necessarily vety useful in the
study of coagulation feactions because there are several pathways along which
clotting-enzymes can be rapidly inactivated.
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The nature of the secondary leactiofl occurring after the formation of an
antigen-antibody complex is determined by the type of antibody. The antibodies
will in any case be directed against specific groups of the antigen molecule, but not
necessarily against those parts of the molecule that cany its enzymatic activity.
Against what part of a coagulation factor an antibody did develop its specificity
remains entirely a matter of chance. So after the primary reaction the active site
of the antigen part of the antigen-antibody complex may remain completely func-
tional, have a changed function, or be completely inhibited. Then, in a secondary
reaction the antigen-antibody complex that initially had its activity preserved
may arter and again loose its activity. A precipitating antibody, for instance,
will remove molecules from the solution; but more subtile changes can occur
too. It is also possible for instance, that combination of an antibody and a
coagulation factor causes quaternary constraints in the latter molecule. This may
lead to a distortion of the tertiary structure surrounding the active part of the
molecule and thus influence its activity even though the active site as such
does not take part in the bonding with the antibody. The slow inactivation by
antibodies as described by Denson for instance (1) may well be due to a teaction
of this type.
In this context it is interesting to note that quaternary constraints brought
about by protein-protein interaction can lead to activation as weil as to inactivation.
This type of activation is seen in the interaction between staphylocoagulase and
prothrombin. Staphylocoagulase does not convert prothrombin into thrombin
enzymatic lly. In all probability, staphylocoagulase complexes with prothrombin
and causes distortion in the zymogen, so that a site with thrombin activity is
generated in the complex (ref. 7, B).
The possibility of the existance of antibodies directed not against protein
factors but against lipoid structures with a functional role in coagulation should
be recognized, too. We already have preliminary evidence that certain types of
antithrombopiastins act by binding not with coagulation factors, but with the
hydrophobic surfaces required for the formation of active complexes of coagulation
factors. It seems as though there is even a kind of specificity here. Some anti-
thtomboplastins preyent the formation of prothrombinase, that is the factor X-
factor V-phospholipid complex. others act one stage higher and interfere with
the formation of the factor IX-factor X-phospholipid cluster (5)
Therefore, the effect of antibodies on a coagulation system by no means has to
consist of the simple titration of a specific factor. The following alternative pos-
sibilities must be taken into consideration:
1. One can expect effects on the number of active molecules avaiTable, not oniy
because of tittation, but also because of the establishment of an equilibrium
that can shift when molecules are occupied in the coagulation process.
\
\
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2. There arc tine effects on the mode of action of the antigen. Coagulation factors
bound by antibodies can have an altered but persisting actiYity.
3. There are the slow effects of quatetnary cqnstraints that can give rise to a
slow alteration of the properties of the complex'
4. The antibodies cafl leact not only with ptoteins but also for example with
the phospholipids necessary fot the ptoteins to be able to function.
Each of these effects will be superimposed upon the coagulation reactions,
and the latter need not follow othodox kinetic laws either. So in concluding,
I can only rcpeat that in these complicated systems it is hardly useful to perform
kinetic analysis by applying standafd rules and fotmulas, even when these seem
to be obeyed by the experimental data. Rathet, one should postulate a reaction
mechanism in tefms of moleculer interactions, and then calculate the expected kinetic
behaviour, exercising due caution with respect to the simplifications required for
the solution of the mathematical problems. Alternative reaction schemes should
be considered as well, and comparison of the results will suggest discriminative
expefiments. This is about the best one can hope fot from the kinetic approach
to problems of antigens in the biochemistry of blood coagulation.
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